Analysts Offer Insights on Healthcare Companies: ClearPoint Neuro (CLPT), BioLife Solutions (BLFS) and Viking Therapeutics (VKTX)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ClearPoint Neuro (CLPT – Research Report), BioLife Solutions (BLFS – Research Report) and Viking Therapeutics (VKTX – Research Report) with bullish sentiments.

Elevate Your Investing Strategy:

• Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

ClearPoint Neuro (CLPT)

Lake Street analyst Frank Takkinen reiterated a Buy rating on ClearPoint Neuro today and set a price target of $30.00. The company’s shares closed last Monday at $26.59.

According to TipRanks.com, Takkinen is a 3-star analyst with an average return of 3.4% and a 40.1% success rate. Takkinen covers the Healthcare sector, focusing on stocks such as Anteris Technologies Global Corp., Inspire Medical Systems, and TriSalus Life Sciences. ;'>

ClearPoint Neuro has an analyst consensus of Moderate Buy, with a price target consensus of $30.00.

See Insiders’ Hot Stocks on TipRanks >>

BioLife Solutions (BLFS)

Lake Street analyst Thomas Flaten reiterated a Buy rating on BioLife Solutions today and set a price target of $30.00. The company’s shares closed last Monday at $26.52.

According to TipRanks.com, Flaten is a 4-star analyst with an average return of 11.9% and a 54.0% success rate. Flaten covers the Healthcare sector, focusing on stocks such as Insight Molecular Diagnostics, Aquestive Therapeutics, and Diamedica Therapeutics. ;'>

Currently, the analyst consensus on BioLife Solutions is a Strong Buy with an average price target of $30.67, a 14.6% upside from current levels. In a report issued on October 1, Craig-Hallum also maintained a Buy rating on the stock.

Viking Therapeutics (VKTX)

In a report released today, Jay Olson from Oppenheimer maintained a Buy rating on Viking Therapeutics, with a price target of $100.00. The company’s shares closed last Monday at $32.28, close to its 52-week low of $24.41.

According to TipRanks.com, Olson is a 4-star analyst with an average return of 8.4% and a 43.6% success rate. Olson covers the Healthcare sector, focusing on stocks such as Sagimet Biosciences, Inc. Class A, Praxis Precision Medicines, and Madrigal Pharmaceuticals. ;'>

Viking Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $89.88, which is a 194.2% upside from current levels. In a report issued on September 22, BTIG also reiterated a Buy rating on the stock with a $125.00 price target.

Read More on CLPT:

Disclaimer & DisclosureReport an Issue

• Largest borrow rate increases among liquid names
• Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
• Why Is ClearPoint Neuro Stock (CLPT) Up Today?
• UniQure (QURE) Stock Jumps 248% on Huntington’s Trial Results. Analysts Raise Price Targets
• Unusually active option classes on open September 24th